• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bronchodilator drugs and their combinations antagonize the dose-related leukotriene D4-induced airway obstruction in guinea pigs.

作者信息

Salonen R O

出版信息

Med Biol. 1985;63(3):137-43.

PMID:2933565
Abstract

The effects of theophylline (THEO), terbutaline (TER), and ipratropium bromide (IPRA), given i.v. alone or in combination, were studied on leukotriene D4 (LTD4)-induced airway obstruction in anaesthetized guinea pigs. LTD4 (0.1-1.6 microgram/kg i.v.) obstructed small airways more than large ones as assessed in terms of relative changes of lung resistance (RL) and dynamic lung compliance (CDyn). A slight tachyphylaxis to LTD4 was observed after repeated administration, especially in the responses of large bronchi. The airway effects of LTD4 were almost totally abolished by prior administration of indomethacin (5 mg/kg i.v.) suggesting a central role of secondarily released cyclo-oxygenase products in this model. THEO (1 to 20 mg/kg) and TER (10 to 400 micrograms/kg) antagonized dose-dependently the LTD4 (0.4 microgram/kg i.v.) induced rise in RL and decrease in CDyn, whereas IPRA (10 to 400 micrograms/kg) failed to show comparably activity. THEO 5 and 20 mg/kg proved highly efficient also on the dose-related airway challenge by LTD4 (0.6 and 1.5 microgram/kg i.v.). Combined treatment with THEO 5 mg/kg + Ter 80 micrograms/kg resulted in an additive effect on RL and CDyn. The combination to THEO 20 mg/kg + TER 80 micrograms/kg was about as effective as THEO 20 mg/kg alone suggesting a nearly maximal effect by the latter treatment. It is concluded that THEO is considerably more efficient on the LTD4-induced airway obstruction than previously observed on the cholinergic model in guinea pigs. Combined treatment with THEO and beta 2-adrenoceptor agonist may antagonize in an additive manner the LTD4 effects on large and small airways.

摘要

相似文献

1
Bronchodilator drugs and their combinations antagonize the dose-related leukotriene D4-induced airway obstruction in guinea pigs.
Med Biol. 1985;63(3):137-43.
2
Actions of bronchodilator drugs, glucocorticoid, and their combinations on airways in rats and guinea pigs.
Acta Pharmacol Toxicol (Copenh). 1985;57 Suppl 3:1-38.
3
Combined actions of bronchodilators in guinea-pigs depend on the severity of cholinergic airway obstruction.
Eur J Pharmacol. 1985 Jan 8;107(3):313-21. doi: 10.1016/0014-2999(85)90256-0.
4
Actions of theophylline, terbutaline, and ipratropium bromide alone and in combinations on the methacholine induced bronchoconstriction in rats.
Acta Pharmacol Toxicol (Copenh). 1982 Oct;51(4):309-20. doi: 10.1111/j.1600-0773.1982.tb01031.x.
5
Modification by betamethasone of the effects of bronchodilator drugs on cholinergic bronchoconstriction in rats.倍他米松对支气管扩张药物对大鼠胆碱能性支气管收缩作用的影响的修饰作用
Br J Pharmacol. 1984 Nov;83(3):607-14. doi: 10.1111/j.1476-5381.1984.tb16214.x.
6
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.SK&F 104353在麻醉豚鼠体内的支气管肺药理学:对肽白三烯反应的强效和选择性拮抗作用的证明
J Pharmacol Exp Ther. 1989 May;249(2):430-7.
7
Reversal of A23187-induced airway constriction in the guinea pig.豚鼠中A23187诱导的气道收缩的逆转
J Pharmacol Exp Ther. 1989 Mar;248(3):1084-90.
8
Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.同工酶选择性磷酸二酯酶抑制剂对豚鼠的肺部抗过敏和支气管扩张作用
J Pharmacol Exp Ther. 1993 Feb;264(2):609-15.
9
[The effects of different inhibitors on the bronchoconstriction induced by leukotriene D4 in the isolated and perfused guinea pig lung].
J Pharmacol. 1985 Jul-Sep;16(3):227-30.
10
In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
J Pharmacol Exp Ther. 1987 Nov;243(2):557-64.